Early Complications After Mild to Moderate Ischemic Stroke and Impact on 3‐Month Outcome: The Multicenter Prospective Stroke Unit Plus Cohort Study
Authors:
- Jan SobeskyJSJan Sobesky
- Vince Istvan MadaiVMVince Istvan Madai
- Sarah ZweynertSZSarah Zweynert
- Carolin MalschCMCarolin Malsch
- Heinrich J. AudebertHAHeinrich J. Audebert
- Christoph KleinschnitzChristoph Kleinschnitz
- Bettina SchmitzBSBettina Schmitz
- Frank Arne WollenweberFWFrank Arne Wollenweber
- Karl Georg HaeuslerKHKarl Georg Haeusler
- Ian WellwoodIWIan Wellwood
Open Access
- 18 February 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (4) , e032068
Abstract
Background: Early stroke complications (ESCs) impair recovery and provide an important therapeutic target. Our multicenter prospective cohort study examined the prevalence and amount of poor outcomes attributable to ESCs. Methods and Results: In patients with stroke, 16 ESCs were monitored by clinical assessment (“basic definition”) and by inclusion of laboratory values and clinical scales (“extended definition”). The association of complications with poor outcome (death or functional impairment: modified Rankin Scale score >3 or Barthel Index <60) at 3 months was analyzed using multiple logistic regression adjusted for stroke severity, age, and sex. Complications were stratified by their early treatment options, and average sequential population‐attributable fractions were estimated for treatable early complications. Of 1202 patients, outcome data were available for 1105 (91.9%; 43.0% women; mean age 68.3 years; baseline median National Institutes of Health Stroke Scale score on admission 3 points). Poor outcome was recorded for 100 patients (9.0%). By basic definition, recurrent stroke, fever, pneumonia, depression, urinary tract infection, and delirium were significantly associated with poor outcomes. The occurrence of 1 or more of these ESCs was associated with up to 19.6% of poor outcomes. By extended definition, urinary tract infection, depression, and delirium were significantly associated with poor outcomes. The occurrence of 1 or more of these ESCs was associated with up to 15.9% of poor outcomes. Conclusions: In our cohort of patients with mild to moderate stroke, we identified a set of treatable ESCs with clinically relevant impact on outcome that may be targeted in future interventional trials. Registration: URL: https://www.bfarm.de ; Unique identifier: DRKS00004712.Keywords
This publication has 47 references indexed in Scilit:
- Processes of Care Associated With Risk of Mortality and Recurrent Stroke Among Patients With Transient Ischemic Attack and Nonsevere Ischemic StrokeJAMA Network Open, 2019
- Participation in Get With The Guidelines–Stroke and Its Association With Quality of Care for StrokeJAMA Neurology, 2018
- Firth's logistic regression with rare events: accurate effect estimates and predictions?Statistics in Medicine, 2017
- Delirium in acute stroke: screening tools, incidence rates and predictors: a systematic reviewJournal of Neurology, 2012
- Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trialThe Lancet, 2011
- Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparisonThe Lancet, 2007
- Predictors of In-Hospital Mortality and Attributable Risks of Death After Ischemic StrokeThe German Stroke Registers Study GroupArchives of internal medicine (1960), 2004
- Sequential and average attributable fractions as aids in the selection of preventive strategiesJournal of Clinical Epidemiology, 1995
- The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adultsJournal of Youth and Adolescence, 1991
- A symptom rating scale for deliriumPsychiatry Research, 1988